Wednesday
Apr182012
AtheroNova ($AHRO) C.E.O. Thomas W. Gardner on atherosclerosis market size (video)
AtheroNova (OTCBB: AHRO) is an early stage biotech company focused on discovery, research, development and licensing of novel compounds to reduce or regress atherosclerotic plaque deposits.
In this film, AtheroNova C.E.O. Thomas W. Gardner speaks about the market size for atherosclerosis:
tagged
ahro,
film annex |
Print Article
Email Article Posted on
Wednesday, April 18, 2012 at 11:48AM
Permalink in
Specialty Pharma







Reader Comments